What’s the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer.
Investors are always on the lookout for the next revolutionary technology or product. In recent times, this has…
After Obtaining Approval for Its Weight Loss Pill, Is It Off to the Races for Eli Lilly Stock?
On April 1, Eli Lilly (NYSE: LLY) and its shareholders received the news they were eagerly awaiting: the…
Alphabet Within Striking Range of $3 Trillion as Key Risk Clears
(Bloomberg) — Alphabet Inc. shares are suddenly unshackled after a long-awaited antitrust ruling removed a key risk that’s…